ECRG4 and breast cancer: Our results showed that administration of this short synthetic peptide (C2ORF40MPF), like overexpression of C2ORF40, could inhibit breast cancer cell proliferation, migration and invasion in vitro and suppress tumor growth in breast cancer xenograft models.